Kanazawa S
Chiba University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kanazawa S.
American Journal of Hematology | 1998
Hideki Tsujimura; Fumitaka Nagamura; Tohru Iseki; Kanazawa S; Hiromitsu Saisho
Elevated levels of parathyroid hormone‐related protein (PTHrP) in hypercalcemic myeloma patients were demonstrated in recent reports, suggesting that PTHrP behaves as a humoral mediator of hypercalcemia in myeloma. Herein we describe a hypercalcemic myeloma patient with a high serum PTHrP level. Moreover, the PTHrP level in the supernatant of bone marrow aspirates was about two‐fold of that in serum. Reverve transcriptase‐polymerase chain reaction analysis showed PTHrP m‐RNA in bone marrow containing myeloma cells. After chemotherapy, the concentrations of calcium and PTHrP decreased and PTHrP mRNA in bone marrow became undetectable. We conclude that PTHrP released by myeloma cells acted as the main bone resorption stimulating factor in this case. Am. J. Hematol. 59:168–170, 1998.
Experimental Biology and Medicine | 1986
Kanazawa S; Terada H; Toru Iseki; Iwasa S; Okuda K; Kondo H
Abstract It is now known that nonphysiological cobalamin analogs exist in the gastrointestinal tract, but their metabolic behavior is unclear. In this study, [57Co]cobinamide was used to study its affinity to hog intrinsic factor-cobalamin (IF-Cbl) receptor which has no species specificity against human IF-Cbl receptor, and its relation to human saliva R binder. Cobinamide was prepared from [57Co]cyanocobalamin and separated by paper chromatography. Human IF-Cbl complex was bound to IF-Cbl receptor but free cyanocobalamin was not. Although R binder-cobinamide was not bound to the IF-Cbl receptor, free cobinamide was bound to the IF-Cbl receptor to a significant extent (about one-half of IF-cyanocobalamin binding to the IF-Cbl receptor). We then investigated the binding of cobinamide to R binder and trypsin-treated R binder. Association constant of cobinamide binding to the IF-Cbl receptor was 1.0 × 109 M -1 which was much lower than that of cobinamide binding to trypsin-treated R binder and to untreated R binder. Further study indicated that cobinamide binding to the IF-Cbl receptor was blocked by the addition of R binder and also by trypsin-treated R binder. We conclude that one of the roles of R binder is to prevent binding of free cobalamin analogs to the IF-Cbl receptor in the gut.
The Lancet | 1983
Kanazawa S; Victor Herbert; Barry Herzlich; G. Drivas; Cathy Manusselis
Journal of Nutritional Science and Vitaminology | 1986
Kanazawa S; Victor Herbert
Acta Haematologica | 1989
Kondo H; Toru Iseki; Iwasa S; Okuda K; Kanazawa S; Ohto M
American Journal of Hematology | 1988
Kanazawa S; Saori Iwasa; Toru Iseki; Okuda K; Kondo H; Kunio Okuda
The Japanese journal of clinical hematology | 1988
Iseki T; Kondo H; Iwasa S; Kunio Okuda; Kanazawa S; Yonemitsu H
The Japanese journal of clinical hematology | 1987
Iseki T; Iwasa S; Kunio Okuda; Kanazawa S; Kondo H; Yonemitsu H
The Japanese journal of clinical hematology | 1989
Kondo H; Kakinuma H; Kanazawa S; Iseki T; Goto S; Ohto M; Yonemitsu H; Kunio Okuda
The Japanese journal of clinical hematology | 1987
Kamei T; Iwasa S; Kunio Okuda; Izeki T; Kanazawa S; Kondo H; Yonemitsu H